Sanofi SA
XBER:SNW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sanofi SA
XBER:SNW
|
FR |
|
Woodside Energy Group Ltd
F:WOP
|
AU |
|
M
|
MFE-MEDIAFOREUROPE NV
MIL:MFEB
|
IT |
|
Constellation Energy Corp
F:E7S
|
US |
|
C
|
Campbell Soup Co
XHAM:CSC
|
US |
|
S
|
Sinopharm Group Co Ltd
SWB:X2S
|
CN |
|
A
|
Arista Networks Inc
SWB:117
|
US |
|
T
|
Talkspace Inc
NASDAQ:TALK
|
US |
|
S
|
SeaWorld Entertainment Inc
XMUN:W2L
|
US |
|
M
|
Mueller Industries Inc
F:MUD
|
US |
|
N
|
Naspers Ltd
XMUN:NNWN
|
ZA |
|
A
|
Altria Group Inc
SWB:PHM7
|
US |
|
D
|
Dycom Industries Inc
F:DYI
|
US |
|
U
|
US Bancorp
BMV:USB
|
US |
|
B
|
Bank Rakyat Indonesia (Persero) Tbk PT
SWB:BYRA
|
ID |
|
Ponce Financial Group Inc
NASDAQ:PDLB
|
US |
|
A
|
AltaGas Ltd
OTC:ATGFF
|
CA |
|
N
|
Newmont Corporation
TSX:NGT
|
US |
|
F
|
Franklin Resources Inc
F:FRK
|
US |
|
V
|
Visteon Corp
F:VS51
|
US |
|
C
|
China Coal Energy Co Ltd
SWB:CVV
|
CN |
|
Everest Group Ltd
NYSE:EG
|
BM |
Bankruptcy Probability
Sanofi SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sanofi SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
PAR:SAN
|
87.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
641.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
357.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
181.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
47.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
213.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sanofi SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sanofi SA has total debt of 16.5B EUR. This includes both short-term (136m EUR) and long-term (16.3B EUR) debt.
You can find a full breakdown on its Balance Sheet.
